Skip to content

ClearPoint Neuro CLPT Free cash flow margin

Free cash flow margin at other companies

Abbott logo
AbbottABT
16.3%+0.6pp
Boston Scientific logo
Boston ScientificBSX
16.9%-0.3pp
IAR
Integra LifeSciencesIART
3.8%-6.3pp
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
17.3%-1.6pp
Medtronic logo
MedtronicMDT
14.9%-0.5pp
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-10.3%-3.5pp

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Calculated from ClearPoint Neuro’s reported figures.

Based on trailing twelve months.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's free cash flow margin?
ClearPoint Neuro (CLPT) reported free cash flow margin of -65.7% in Q1 2026.
How has ClearPoint Neuro's free cash flow margin changed year-over-year?
ClearPoint Neuro's free cash flow margin decreased by 80.4% year-over-year, from -36.4% to -65.7%.
What is the long-term trend for ClearPoint Neuro's free cash flow margin?
Over 5 years (2020 to 2025), ClearPoint Neuro's free cash flow margin has grown at a 1.5% compound annual growth rate (CAGR), from -61.2% to -66.1%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.